vTv Therapeutics

FDA stop sign
Biotech

FDA puts vTv's diabetes drug on hold over chromatographic signal

The FDA has placed vTv’s phase 3 trial for cadisegliatin on hold, two years after the biotech stacked its remaining chips on the Type 1 diabetes drug.
James Waldron Jul 29, 2024 4:47am
image of a few paragliders

New federal biotech commission taps 12 members—Chutes & Ladders

Feb 3, 2023 10:20am
CL paragliding mountain

Amgen vet to be CMO at Affini-T—Chutes & Ladders

Jul 29, 2022 9:30am
exit sign

vTv CEO resigns four months in and board member takes over

Mar 4, 2022 9:50am
Parachute

Athira CEO resigns after investigation—Chutes & Ladders

Oct 22, 2021 9:30am
Traffic at a red stoplight brake lights reflected in wet road

vTv's Alzheimer's drug azeliragon flops in phase 3 again

Jun 13, 2018 10:24am